EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Predictors of Pathologic Complete Response and Its Prognostic Value in Early Breast Cancer: A Real-World Cohort Study

Selami Bayram iD, Ali Murat Tatli, Muharrem Okan Cakir iD, Mustafa Ozdogan

Current Oncology · 28.10.2025 · 32 (11) · 603

DOI: 10.3390/curroncol32110603 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Current Oncology, online erschienen am 28.10.2025. Verfasst von Selami Bayram und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Memorial Antalya Hospital, 07025 Antalya, Türkiye. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pathologic complete response (pCR) after neoadjuvant systemic therapy (NAST) is a key prognostic marker in early breast cancer (EBC), particularly in triple-negative (TNBC) and HER2-positive subtypes. However, real-world data on predictors of pCR and their impact on survival remain limited.

Methods

We retrospectively analyzed 200 patients with stage II–III EBC treated with NAST at a single institution (2015–2023). Clinicopathologic variables and treatment characteristics were evaluated for association with pCR (ypT0/is ypN0), and histological regression was additionally assessed using the Miller–Payne scoring system. Multivariable logistic regression identified independent predictors. Disease-free survival (DFS) and overall survival (OS) were estimated using Kaplan–Meier methods.

Results

Overall, 36.0% achieved pCR, with the highest rates in HER2-positive (65%) and TNBC (56%) subtypes. Independent predictors of pCR included HER2 positivity (OR 4.21, 95% CI 1.83–9.67, p < 0.001), high Ki-67 > 47.5% (OR 3.62, 95% CI 1.68–7.80, p = 0.001), ER < 10% (OR 2.77, 95% CI 1.18–6.50, p = 0.019), and radiologic complete response (OR 10.03, 95% CI 2.91–34.60, p < 0.001). At a median follow-up of 75 months, compared with non-pCR, patients achieving pCR had a significantly lower risk of recurrence (HR 0.16, 95% CI 0.04–0.70, p = 0.014) with 5-year DFS rates of 91.5% vs. 72.8%. For OS, pCR patients showed a lower risk of death (HR 0.33, 95% CI 0.07–1.49, p = 0.150), corresponding to 5-year OS of 92.2% vs. 87.0%, although this difference was not statistically significant.

Conclusions

HER2 positivity, high Ki-67, low ER expression, and radiologic complete response are independent predictors of pCR. Achieving pCR strongly correlates with improved DFS but not OS, likely due to limited sample size and event number. These findings reinforce pCR as a surrogate endpoint in TNBC and HER2-positive disease and highlight the need for post-neoadjuvant escalation in non-pCR patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleMiddle AgedPrognosisRetrospective StudiesAdultAgedNeoadjuvant TherapyCohort StudiesErb-b2 Receptor Tyrosine KinasesPathologic Complete Response

Stichwörter der Autor:innen

HER2-positive breast cancerbreast neoplasmsdisease-free survivalearly breast cancerneoadjuvant therapypathologic complete responsepredictive biomarkersprognosistriple-negative breast cancer

Substanzen

Erb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Medical Oncology, Memorial Antalya Hospital, 07025 Antalya, Türkiye.
  • School of Life Science, Pharmacy and Chemistry, Kingston University London, London KT1 2EE, UK.

ORCID-Profile: Selami Bayram, Muharrem Okan Cakir

Zitieren

APA

Bayram, S., Tatli, A. M., Cakir, M. O., & Ozdogan, M. (2025). Predictors of Pathologic Complete Response and Its Prognostic Value in Early Breast Cancer: A Real-World Cohort Study. Current Oncology, 32(11), 603. https://doi.org/10.3390/curroncol32110603

Vancouver

Bayram S, Tatli AM, Cakir MO, Ozdogan M. Predictors of Pathologic Complete Response and Its Prognostic Value in Early Breast Cancer: A Real-World Cohort Study. Current Oncology. 2025;32(11):603. doi:10.3390/curroncol32110603

BibTeX
@article{Bayram2025,
  author = {Bayram, Selami and Tatli, Ali Murat and Cakir, Muharrem Okan and Ozdogan, Mustafa},
  title = {Predictors of Pathologic Complete Response and Its Prognostic Value in Early Breast Cancer: A Real-World Cohort Study},
  journal = {Current Oncology},
  year = {2025},
  volume = {32},
  number = {11},
  pages = {603},
  doi = {10.3390/curroncol32110603}
}
Kostenlos starten →